Correlation between EpCAM expression and cervical lymph node metastasis in papillary thyroid carcinoma: a study integrating ultrasonographic features
- PMID: 40307718
- DOI: 10.1186/s12885-025-14034-x
Correlation between EpCAM expression and cervical lymph node metastasis in papillary thyroid carcinoma: a study integrating ultrasonographic features
Abstract
Objectives: The epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that is overexpressed in various epithelial tumors and has been associated with tumor aggressiveness and unfavorable prognosis. This study aimed to explore the association between ultrasonic characteristics and EpCAM expression in papillary thyroid carcinoma (PTC), as well as the value in predicting the risk of cervical lymph node metastasis (CLNM).
Methods: Participants with suspected thyroid cancer underwent conventional and contrast-enhanced ultrasonography (CEUS) before surgery. Age, sex, and nodule features in ultrasound were recorded. Participants were classified based on the presence of CLNM. EpCAM expression was detected using immunohistochemistry. The risk predictors of CLNM were evaluated by using univariate and multivariate Cox model.
Results: The final dataset included 53 participants, of whom 27(50.94%) had CLNM, while 26(49.06%) did not. The EpCAM-positive area (p < 0.001), score (p < 0.001), and nuclear expression (p = 0.027) were significantly different between the CLNM and non-CLNM groups. Receiver operating characteristic curve analysis showed that EpCAM score with 4.5 had sensitivity and specificity of 85.2% and 76.9%, respectively, for diagnosing CLNM. Multivariate logistic regression results showed that overexpression EpCAM (score ≧ 4.5) [OR:46.54, p = 0.007], tumor size ≧ 1.05 cm [OR:14.21,p = 0.01] and extrathyroidal extension (ETE) on CEUS [OR:113.33, p = 0.01] were independent risk factors of CLNM. Overexpression of EpCAM (62.07%, 18/29) correlated with ETE of PTC confirmed by postoperative pathology (p = 0.01, 0.027). No significant difference in PTC histological variants was detected based on EpCAM expression (p = 0.05).
Conclusions: EpCAM overexpression demonstrated a significant association with ETE and CLNM in PTC. The integration of ultrasonography with EpCAM expression profiling offers A promising multiparameter diagnostic model to enhance predictive accuracy. Further studies evaluating EpCAM expression in fine-needle aspiration biopsy (FNAB) samples are required to determine its possible preoperative predictive value.
Keywords: Cervical lymph node metastasis; Extrathyroidal extension; Papillary thyroid carcinoma; Ultrasonography.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval: The studies involving human participants were reviewed and approved by Medical Ethics Committee of Chinese PLA General Hospital. Written informed consent was obtained from the individuals for the publication of any potentially identifiable images or data included in this article. Competing interests: The authors declare no competing interests.
Similar articles
-
A radiopathomics model for predicting large-number cervical lymph node metastasis in clinical N0 papillary thyroid carcinoma.Eur Radiol. 2025 Aug;35(8):4587-4598. doi: 10.1007/s00330-025-11377-8. Epub 2025 Jan 29. Eur Radiol. 2025. PMID: 39881038
-
The value of ultrasonographic scoring method and nomogram in assessing cervical lymph node metastasis of papillary thyroid carcinoma.Thyroid Res. 2025 Jul 22;18(1):36. doi: 10.1186/s13044-025-00255-6. Thyroid Res. 2025. PMID: 40691855 Free PMC article.
-
Ongoing discussion: Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary thyroid cancer?Tumori. 2025 Aug;111(4):302-309. doi: 10.1177/03008916251334884. Epub 2025 Jun 3. Tumori. 2025. PMID: 40462273
-
Determination of lymph node metastasis using quantitative ultrasound elastography of papillary thyroid carcinoma nodule: a systematic review and meta-analysis.BMC Med Imaging. 2025 Aug 21;25(1):342. doi: 10.1186/s12880-025-01858-z. BMC Med Imaging. 2025. PMID: 40841628 Free PMC article.
-
Ultrasound-based artificial intelligence for predicting cervical lymph node metastasis in papillary thyroid cancer: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2025 Jun 10;16:1570811. doi: 10.3389/fendo.2025.1570811. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40556829 Free PMC article.
References
-
- Sun Y, Dai W, Liang Y, Xia N. Impact of age on the prognosis of papillary thyroid carcinoma. Arch Iran Med. 2020;23(3):169–74.
-
- Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A. Overall survival of papillary thyroid carcinoma participants: A Single-Institution Long-Term Follow-up of 5897 participants. Word J Surg. 2018;42(3):615–22. https://doi.org/10.1007/s00268-018-4479-z . - DOI
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. https://doi.org/10.3322/caac.21551 . - DOI
-
- Hay ID, McConahey WM, Goellner JR. Managing participants with papillary thyroid carcinoma: insights gained from Mayo clinic’s experience of treating 2,512 consecutive participants during 1940 through 2000. Trans Am Clin Climatol Assoc. 2002;113:241–60.
-
- Tuttle RM, Leboeuf R, Martorella AJ. Papillary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am (2007) 36 (3): 753– 78. doi: org/ https://doi.org/10.1016/j.ecl.2007.04.004
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous